These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16495766)

  • 21. [Reducing blood pressure and modification of coronary risk factors by therapy with doxazosin].
    Hitzenberger G; Ganzinger U
    Wien Klin Wochenschr; 1993; 105(13):371-6. PubMed ID: 8351927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of doxazosin GITS on blood pressure in hypertensive and normotensive patients: a review of hypertension and BPH studies.
    Lund-Johansen P; Kirby RS
    Blood Press Suppl; 2003 May; 1():5-13. PubMed ID: 12800982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension.
    Gleim GW; Rubino J; Zhang H; Shahinfar S; Soffer BA; Lyle PA; Littlejohn TW; Feig PU
    Clin Ther; 2006 Oct; 28(10):1639-48. PubMed ID: 17157119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Randomized, comparative study to evaluate efficacy and safety of doxazosin versus nitrendipine in the treatment of mild to moderate hypertension].
    Sanz Guajardo D; Espejo Martínez J
    An Med Interna; 1997 Jan; 14(1):15-9. PubMed ID: 9091027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Administration-time-dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects.
    Hermida RC; Calvo C; Ayala DE; Domínguez MJ; Covelo M; Fernández JR; Fontao MJ; López JE
    Chronobiol Int; 2004 Mar; 21(2):277-96. PubMed ID: 15332347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy and tolerance of doxazosin in the treatment of isolated systolic hypertension in hypertensive patients over 60 years of age].
    Calvo C; López E; Barrio E; Espejo J; Ruiz M; Vega A
    An Med Interna; 1995 Mar; 12(3):122-6. PubMed ID: 7795118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of doxazosin gastrointestinal therapeutic system on platelet degranulation and platelet-leukocyte microaggregate formation induced by physiologic shear stress in hypertension.
    Labiós M; Martínez M; Gabriel F; Guiral V; Aznar J
    Thromb Res; 2006; 118(4):447-53. PubMed ID: 16242179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doxazosin GITS versus hydrochlorothiazide as add-on therapy in patients with uncontrolled hypertension.
    Campo C; Segura J; Roldán C; Alcázar JM; Rodicio JL; Ruilope LM
    Blood Press Suppl; 2003 Dec; 2():16-21. PubMed ID: 14761072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood pressure and blood glucose levels during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients.
    Ahaneku JE
    Kobe J Med Sci; 1996 Feb; 42(1):19-29. PubMed ID: 8984227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind placebo-controlled study evaluating the onset of action of doxazosin gastrointestinal therapeutic system in the treatment of benign prostatic hyperplasia.
    Roehrborn CG; Prajsner A; Kirby R; Andersen M; Quinn S; Mallen S
    Eur Urol; 2005 Sep; 48(3):445-52; discussion 452. PubMed ID: 15996811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doxazosin in hypertension: results of a general practice study in 4809 patients.
    Langdon CG; Packard RS
    Br J Clin Pract; 1994; 48(6):293-8. PubMed ID: 7848789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of tamsulosin hydrochloride compared to doxazosin in the treatment of Indonesian patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
    Rahardjo D; Soebadi DM; Sugandi S; Birowo P; Djati W; Wahyudi I
    Int J Urol; 2006 Nov; 13(11):1405-9. PubMed ID: 17083392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nationwide efficacy-safety study of nebivolol in mildly hypertensive patients.
    Cleophas TJ; Agrawal R; Lichtenthal A; Mäkel W; Fici F
    Am J Ther; 2006; 13(3):192-7. PubMed ID: 16772759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter, community-based study of doxazosin in the treatment of concomitant hypertension and symptomatic benign prostatic hyperplasia: the Hypertension and BPH Intervention Trial (HABIT).
    Guthrie RM; Siegel RL
    Clin Ther; 1999 Oct; 21(10):1732-48. PubMed ID: 10566569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment.
    Toth K; Kesmarky G; Vekasi J; Nemes J; Czopf L; Kapronczay P; Halmosi R; Papp E; Juricskay I
    Clin Hemorheol Microcirc; 1999; 21(3-4):209-16. PubMed ID: 10711745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of home measurement and ambulatory monitoring of blood pressure in the adjustment of antihypertensive treatment.
    Niiranen TJ; Kantola IM; Vesalainen R; Johansson J; Ruuska MJ
    Am J Hypertens; 2006 May; 19(5):468-74. PubMed ID: 16647616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
    Saito I; Saruta T;
    Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Doxazosine associated to renin-angiotensin blockers and calcioantagonists in chronic renal failure patients].
    Robles NR; Gómez Campderá F; Ocón I; Manjón M; Pastors L; Herrera J; Villatoro J; Calls I; Torrijos I; Rodríguez Villareal I; Rodríguez Martínez MA; Méndez ML; Morey A; Martínez Fernández I; Marco I; Liébana A; Rincón B; Tornero F
    Nefrologia; 2005; 25(5):515-20. PubMed ID: 16392301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of alpha 1-blockers in combination therapy for hypertension.
    Zusman RM
    Int J Clin Pract; 2000; 54(1):36-40. PubMed ID: 10750258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The addition of doxazosin to the therapeutic regimen of hypertensive patients inadequately controlled with other antihypertensive medications: a randomized, placebo-controlled study.
    Black HR; Sollins JS; Garofalo JL
    Am J Hypertens; 2000 May; 13(5 Pt 1):468-74. PubMed ID: 10826396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.